Medical IP is a technology company specializing in providing digital twin solutions for use in the healthcare industry. The company’s primary solution, MEDIP PRO, is able to process medical images and support the creation of digital twins. The solution uses AI to automatically differentiate and model various organs with the click of a button. The solution has received regulatory clearances, including FDA 510(K), CE marking, Medicines and Healthcare Products Regulatory Agency-registered, and Ministry of Food and Drug Safety-approved.
Key customers and partnerships
Medical IP’s notable customers include Seoul National University Hospital, Samsung Medical Center, Gangnam Severance Hospital, Mayo Clinic, UCLA, and Arizona State University.
The company partnered with NVIDIA in May 2023, enabling users to connect medical image analysis from the MEDIP PRO platform with NVIDIA’s Omniverse technology for the creation of digital twins.
Additionally, the company has transitioned its cloud infrastructure to Amazon Web Services in March 2023, which is HIPAA-eligible. The partnership is focusing on implementing AWS in the US, China, and Middle East markets.
Funding and financials
In May 2021, the company raised USD 20 million via a Series C funding round.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.